| |
| |
|
| Insider
Information: |
Otoole David D |
| Relationship: |
Chief Financial Officer |
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
158,937 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$381,300 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
158,937 |
|
|
| Total
Value |
$381,300 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
5
|
|
Stock
price went up :
|
3
|
4
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
4.0
|
| Percentage
Gain/Loss : |
 18.5%
|
21.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Response Genetics Inc |
RGDX |
Officer |
2010-05-03 |
3,500 |
|
0 |
Premium* |
|
|
Codexis Inc |
CDXS |
SVP & Chief Financial ... |
2013-09-04 |
110,687 |
2012-09-10 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
See Remarks |
2016-08-18 |
44,750 |
2015-03-13 |
0 |
Premium* |
|
|
Opiant Pharmaceuticals Inc |
OPNT |
Chief Financial Officer |
2023-03-02 |
0 |
2018-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2021-08-16 |
4 |
B |
$15.38 |
$9,228 |
D/D |
600 |
23,815 |
2.74 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-08-14 |
4 |
B |
$15.39 |
$15,636 |
D/D |
1,015 |
6,015 |
2.74 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2019-08-13 |
4 |
B |
$15.46 |
$15,460 |
D/D |
1,000 |
7,015 |
2.74 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-05-16 |
4 |
B |
$16.95 |
$33,900 |
D/D |
2,000 |
5,000 |
2.74 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2018-05-11 |
4 |
B |
$18.85 |
$56,550 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2021-09-14 |
4 |
B |
$19.05 |
$3,824 |
D/D |
200 |
24,015 |
2.66 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
D |
$20.00 |
$724,960 |
D/D |
(36,248) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-01-05 |
4 |
S |
$20.20 |
$32,320 |
D/D |
(1,600) |
35,204 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-01-09 |
4 |
S |
$20.20 |
$8,383 |
D/D |
(415) |
34,789 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2023-01-27 |
4 |
S |
$20.26 |
$10,961 |
D/D |
(541) |
34,248 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2022-01-10 |
4 |
S |
$30.60 |
$13,219 |
D/D |
(432) |
35,583 |
0 |
% |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
